Latest AI and machine learning research in other cancers for healthcare professionals.
Despite rapid advances in multi-omics technologies, translating candidate biomarkers into clinical practice for bladder cancer remains challenging due to the difficulty of linking complex genomic instability to interpretable biological processes. To address this, we developed an AI-driven multi-omics discovery framework integrating single-cell RNA sequencing, multi-cohort transcriptomics, and mach...
Background Some artificial intelligence models use heart rate variability (HRV) features to classify sleep stages. Estimation of HRV indices requires the removal of outliers and correction of ectopic beats from the electrocardiography (ECG) data. In addition, sleep epochs bear a temporal relationship to each other, while classifiers treat epochs as independent entities. To address this, we propose...
BACKGROUND/AIM: Colorectal cancer liver metastases (CRLM) remain a leading cause of cancer-related mortality. Although hepatic resection is the only e...
BACKGROUND: Sleep disorders and anxiety-depression symptoms can significantly impair the quality of life and treatment adherence among breast cancer p...
Recent advancements in AI have emerged in the diagnosis of different diseases by enhancing the analysis of various medical imaging. Similarly, the eng...
INTRODUCTION: Clinical management of RAS wild-type colorectal cancer liver metastases (CRLM) remains challenging because many patients exhibit primary...
BACKGROUND: Early detection and management are essential in hepatocellular carcinoma (HCC) care. Artificial intelligence (AI) is enhancing the precisi...
Artificial intelligence (AI)-based decision support systems are increasingly explored in surgical oncology. However, their concordance with multidisci...
BACKGROUND: ∼60%-70% of patients with metastatic non-small cell lung cancer (NSCLC) have relatively low tumor mutational burden (TMB), with limited bi...
Prostate-specific membrane antigen (PSMA) PET/CT is routinely used to restage prostate cancer (PCa) in patients with biochemical recurrence (BCR), yet...
Cancer is characterized by extensive genetic variability, continuous evolutionary change, and intricate interactions with its surrounding microenviron...
Hepatocellular carcinoma (HCC) treatment faces significant challenges, particularly in tumor growth, metastasis, and drug resistance. While several pr...
Bisphenol A (BPA), a ubiquitous environmental endocrine-disrupting chemical extensively used in plastic products, has been increasingly recognized for...
Endoscopic retrograde cholangiopancreatography (ERCP)-based tissue acquisition is the cornerstone for assessment of suspected malignant biliary strict...
Although significant progress has been achieved in diagnosing papillary thyroid carcinoma (PTC), it remains a challenge to diagnose thyroid nodules (T...
OBJECTIVE: Dysregulation of Protein post-translation(PTM) and Treg/Th17 balance contribute to the progression of Hepatocellular Carcinoma(HCC) patient...
BACKGROUND: Aspartame (APM), a widely used sweetener, has been linked to cancers, yet its molecular impact on metabolic dysfunction-associated steatot...
Colorectal cancer (CC) arises from a complex interplay between genetic and epigenetic alterations within the colorectal mucosa, resulting in unchecked...
BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of primary pulmonary neoplasms. Complete surgical removal remains the co...
The hallmarks of cancer were introduced by Hanahan and Weinberg as a conceptual organizing framework to distil the complexity of tumours. This concept...